Similar to anti-amyloid antibodies, focused ultrasound has been used as an effective strategy to enhance the delivery of anti-tau antibodies in AD models (Jordão et al., 2010; Nisbet et al., 2017; Janowicz et al., 2019; Xhima et al., 2020). This evidence concerns the gene MAPT and Alzheimer disease.